Page last updated: 2024-08-23

desogestrel and Bone Loss, Perimenopausal

desogestrel has been researched along with Bone Loss, Perimenopausal in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Sobel, NB	1
Cappagli, B; Fioretti, P; Gambacciani, M; Piaggesi, L; Spinetti, A; Taponeco, F	1
Byrjalsen, I; Christiansen, C; Haarbo, J	1
Benussi, C; Cappagli, B; Ciaponi, M; Gambacciani, M; Genazzani, AR	1
Christiansen, C; Marslew, U; Riis, BJ	1

Reviews

1 review(s) available for desogestrel and Bone Loss, Perimenopausal

Article	Year
Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages? Obstetrics and gynecology clinics of North America, 1994, Volume: 21, Issue:2 Topics: Breast Neoplasms; Cardiovascular Diseases; Desogestrel; Endometrium; Estrogen Replacement Therapy; Female; Humans; Norgestrel; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone Congeners; Risk Factors; Structure-Activity Relationship	1994

Article

Year

Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?

Obstetrics and gynecology clinics of North America, 1994, Volume: 21, Issue:2

Topics: Breast Neoplasms; Cardiovascular Diseases; Desogestrel; Endometrium; Estrogen Replacement Therapy; Female; Humans; Norgestrel; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone Congeners; Risk Factors; Structure-Activity Relationship

1994

Trials

4 trial(s) available for desogestrel and Bone Loss, Perimenopausal

Article	Year
Longitudinal evaluation of perimenopausal vertebral bone loss: effects of a low-dose oral contraceptive preparation on bone mineral density and metabolism. Obstetrics and gynecology, 1994, Volume: 83, Issue:3 Topics: Adult; Analysis of Variance; Bone Density; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Longitudinal Studies; Middle Aged; Osteoporosis, Postmenopausal; Regression Analysis; Spine	1994
Role of cigarette smoking on the postmenopausal endometrium during sequential estrogen and progestogen therapy. Obstetrics and gynecology, 1993, Volume: 81, Issue:6 Topics: Desogestrel; Endometrium; Estradiol; Estradiol Dehydrogenases; Estrogen Replacement Therapy; Female; Glycodelin; Glycoproteins; Humans; Isocitrate Dehydrogenase; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal; Pregnancy Proteins; Smoking	1993
Hormone replacement therapy in perimenopause: effect of a low dose oral contraceptive preparation on bone quantitative ultrasound characteristics. Menopause (New York, N.Y.), 1999,Spring, Volume: 6, Issue:1 Topics: Adult; Analysis of Variance; Biomarkers; Bone Density; Contraceptives, Oral, Synthetic; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Hormone Replacement Therapy; Humans; Hydroxyproline; Longitudinal Studies; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Premenopause; Reference Values; Ultrasonography	1999
Desogestrel in hormone replacement therapy: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding. European journal of clinical investigation, 1991, Volume: 21, Issue:6 Topics: Absorptiometry, Photon; Bone Density; Calcium; Climacteric; Desogestrel; Drug Therapy, Combination; Estradiol; Female; Humans; Lipids; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone Congeners	1991